The content on this platform is grounded in the peer-reviewed publications of the scientists who have defined the field — from the isolation of THC in 1964 to the FDA approval of Epidiolex in 2018.
Every health claim, dosing guideline, and mechanism explanation on this platform is traceable to peer-reviewed publications by the researchers below. Our editorial process requires:
Listed with verifiable credentials, institutions, and PubMed publication records
Areas of Expertise
Cannabinoid chemistry, THC isolation, endocannabinoid system discovery
Known as the "father of cannabis research," Prof. Mechoulam first isolated and synthesized THC in 1964 and CBD in 1963. He co-discovered anandamide (the endogenous cannabinoid) in 1992. Author of over 400 peer-reviewed publications. Recipient of the Israel Prize (2000) and the Harvey Prize (2011). His foundational work underpins virtually all modern cannabis science.
Key Publications
Areas of Expertise
Clinical cannabinoid medicine, terpene-cannabinoid interactions, entourage effect, pain neurology
Dr. Russo is one of the world's foremost clinical authorities on cannabinoid medicine. He coined and formalized the "entourage effect" hypothesis and the "clinical endocannabinoid deficiency" (CECD) theory. Former Senior Medical Advisor at GW Pharmaceuticals (makers of Epidiolex/Sativex). Author of over 50 peer-reviewed papers and multiple book chapters on cannabis therapeutics.
Key Publications
Areas of Expertise
Cannabis clinical trials, neuropsychiatry, HIV/AIDS neurology, pain management
Dr. Grant directs the CMCR at UCSD — the largest state-funded cannabis research program in the United States. He has overseen more than a dozen FDA-approved clinical trials on smoked and vaporized cannabis for pain, spasticity, and neuropathy. His work provides some of the most rigorous clinical evidence for medical cannabis in the U.S. literature.
Key Publications
Areas of Expertise
Cannabis for cancer symptom management, HIV/AIDS, integrative oncology, pain
Dr. Abrams is a pioneer in clinical cannabis research, having conducted some of the first FDA-approved trials on smoked cannabis in HIV/AIDS patients in the 1990s. He has published extensively on cannabis for cancer-related pain, nausea, and appetite loss, and is co-editor of the landmark textbook "Integrative Oncology" (Oxford University Press). A leading voice for evidence-based integration of cannabis into oncology care.
Key Publications
Areas of Expertise
Epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, CBD clinical trials, treatment-resistant seizures
Dr. Devinsky led the pivotal Phase III clinical trials of cannabidiol (Epidiolex) that resulted in the first FDA approval of a cannabis-derived drug in 2018. His landmark NEJM publications on CBD for Dravet syndrome and Lennox-Gastaut syndrome are among the most cited papers in cannabis medicine. He continues to lead research on cannabinoids for treatment-resistant epilepsy.
Key Publications
Areas of Expertise
PTSD, anxiety, cannabis use disorder, cannabinoid pharmacology, veteran health
Dr. Bonn-Miller is a leading researcher on cannabis use in PTSD and anxiety disorders, with particular focus on veteran populations. He has published over 100 peer-reviewed papers on cannabis and mental health, and has served as a consultant to the FDA, DEA, and multiple state medical cannabis programs. His work on CBD product accuracy (2017 JAMA study) directly influenced FDA regulatory policy.
Key Publications
Areas of Expertise
Chronic pain, cannabis clinical trials, medical cannabis policy, neuropathic pain
Dr. Ware is one of Canada's foremost cannabis researchers and clinicians, having conducted landmark RCTs on smoked cannabis for neuropathic pain. He chaired the Canadian Task Force on Cannabis for Medical Purposes and served on Health Canada's expert advisory committee. His CMAJ-published RCTs on cannabis for post-traumatic neuropathic pain are foundational references in the field.
Key Publications
Areas of Expertise
Botanical pharmacology, cannabinoid receptor pharmacodynamics, minor cannabinoid research, biochemical standardization, quality assurance for botanical manufacturing, global health systems integration
Dr. Scott is an applied research scientist with 15+ years of experience bridging traditional ethnobotanical knowledge with contemporary biomedical science. He has developed biochemical standardization protocols for plant-derived compounds, established quality assurance frameworks for botanical manufacturing, and advanced research into cannabinoid receptor pharmacodynamics and minor cannabinoids. His interdisciplinary background spans emergency medicine, medical instruction, healthcare administration, and health systems science. His work promotes rigorous, standardized, and clinically responsible approaches to plant-based therapeutics through evidence-based methodology and regulatory-aligned production standards.
Key Publications
All health claims cite studies published in indexed, peer-reviewed journals. No anecdotal or non-peer-reviewed sources are presented as clinical evidence.
Every claim is labeled with its evidence level — RCT, meta-analysis, systematic review, preclinical, or observational — so readers can assess the strength of the evidence themselves.
All condition guides, cannabinoid profiles, and health content are reviewed against new publications quarterly. Last review dates are displayed on each page.
Important Disclaimer: The researchers listed on this page are not affiliated with, employed by, or endorsing this platform. Their published research is cited as the scientific basis for our content in accordance with standard academic practice. This platform does not provide individual medical advice. Always consult a qualified healthcare professional before making any medical decisions.